SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,116.29 -399.14
( -0.52%)

Global Indices

Nasdaq

53,423.66 -283.45
(-0.53%)

Dow Jones

7,737.34 -31.37
(-0.40%)

Hang Seng

65,002.68 788.20
(1.23%)

Nikkei 225

10,828.70 -2.82
(-0.03%)

Forex

USD-INR

94.48 -0.24
(-0.26%)

EUR-INR

109.71 0.00
(0.00%)

GBP-INR

127.63 -0.19
(-0.15%)

JPY-INR

0.60 0.01
(1.60%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Mercury Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

538964

INE947G01011

484

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

20.52

90.12

EPS(TTM)

Face Value()

Div & Yield %

36.59

0.47

Back

thakkers group ltd

REC consolidated net profit declines 6.11% in the June 2026 quarter

Jul 25,2026

Net profit of REC declined 6.11% to Rs 4192.76 crore in the quarter ended June 2026 as against Rs 4465.71 crore during the previous quarter ended June 2025. Sales declined 2.05% to Rs 14434.92 crore in the quarter ended June 2026 as against Rs 14737.45 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	14434.92	14737.45	-2
OPM %	96.90	98.53	-
PBDT	5275.09	5673.11	-7
PBT	5268.30	5666.41	-7
NP	4192.76	4465.71	-6

76,116.29 -399.14 ( -0.52%)

53,423.66 -283.45 (-0.53%)

7,737.34 -31.37 (-0.40%)

65,002.68 788.20 (1.23%)

10,828.70 -2.82 (-0.03%)

94.48 -0.24 (-0.26%)

109.71 0.00 (0.00%)

127.63 -0.19 (-0.15%)

0.60 0.01 (1.60%)